{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T07:15:09Z","timestamp":1783062909034,"version":"3.54.6"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T00:00:00Z","timestamp":1777766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-51181-y","type":"journal-article","created":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T05:36:20Z","timestamp":1777786580000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhanced immunogenicity of the rabies virus glycoprotein fused to a dendritic cell-targeting peptide"],"prefix":"10.1038","volume":"16","author":[{"given":"Atousa","family":"Bakhsheshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fattah","family":"Sotoodehnejadnematalahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Gholami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Ajorloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,3]]},"reference":[{"issue":"5","key":"51181_CR1","doi-asserted-by":"publisher","first-page":"264","DOI":"10.29252\/ibj.24.5.263","volume":"24","author":"A Gholami","year":"2020","unstructured":"Gholami, A. & Alamdary, A. The world rabies day 2020: Collaborate and vaccinate. Iran. Biomed. J. 24 (5), 264\u2013268 (2020).","journal-title":"Iran. Biomed. J."},{"key":"51181_CR2","doi-asserted-by":"publisher","first-page":"127787","DOI":"10.1016\/j.vaccine.2025.127787","volume":"65","author":"MA Ashwini","year":"2025","unstructured":"Ashwini, M. A. et al. Immunogenicity of the abbreviated one-week intradermal rabies pre-exposure prophylaxis and its boostability in health-care workers: A retrospective observational cohort study. Vaccine 65, 127787 (2025).","journal-title":"Vaccine"},{"key":"51181_CR3","doi-asserted-by":"crossref","unstructured":"Smekenov, I. et al. Immunogenicity and antigenicity of the recombinant ectodomain of rabies virus glycoprotein containing the human collagen XVIII trimerization domain. Vaccines (Basel). 13(9). (2025).","DOI":"10.3390\/vaccines13090971"},{"issue":"1","key":"51181_CR4","doi-asserted-by":"publisher","first-page":"104","DOI":"10.52547\/vacres.8.1.104","volume":"8","author":"A Alamdary","year":"2021","unstructured":"Alamdary, A. et al. Construction and rescue of a rabies virus with duplicated glycoprotein gene. Vacres. 8 (1), 104 (2021).","journal-title":"Vacres"},{"key":"51181_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4103\/abr.abr_480_24","volume":"14","author":"A Alamdary","year":"2025","unstructured":"Alamdary, A. et al. Duplication of the rabies virus glycoprotein enhances the virus propagation rate and immunogenicity. Adv. Biomed. Res. 14, 75 (2025).","journal-title":"Adv. Biomed. Res."},{"key":"51181_CR6","doi-asserted-by":"crossref","unstructured":"Khudainazarova, N. S. et al. Prokaryote- and eukaryote-based expression systems: Advances in post-pandemic viral antigen production for vaccines. Int. J. Mol. Sci. 25(22). (2024).","DOI":"10.3390\/ijms252211979"},{"key":"51181_CR7","doi-asserted-by":"crossref","unstructured":"Natesan, K. et al. Developments in rabies vaccines: The path traversed from pasteur to the modern era of immunization. Vaccines (Basel). 11(4). (2023).","DOI":"10.3390\/vaccines11040756"},{"issue":"1","key":"51181_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.vetmic.2014.03.037","volume":"171","author":"Q Wu","year":"2014","unstructured":"Wu, Q. et al. Rabies-virus-glycoprotein-pseudotyped recombinant baculovirus vaccine confers complete protection against lethal rabies virus challenge in a mouse model. Vet. Microbiol. 171 (1), 93\u2013101 (2014).","journal-title":"Vet. Microbiol."},{"issue":"10","key":"51181_CR9","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1128\/CVI.05258-11","volume":"18","author":"R Ramya","year":"2011","unstructured":"Ramya, R. et al. Expression and solubilization of insect cell-based rabies virus glycoprotein and assessment of its immunogenicity and protective efficacy in mice. Clin. Vaccine Immunol. 18 (10), 1673\u20131679 (2011).","journal-title":"Clin. Vaccine Immunol."},{"key":"51181_CR10","doi-asserted-by":"publisher","first-page":"595841","DOI":"10.3389\/fimmu.2020.595841","volume":"11","author":"SB Boscardin","year":"2020","unstructured":"Boscardin, S. B. et al. Editorial: Harnessing the participation of dendritic cells in immunity and tolerance. Front. Immunol. 11, 595841 (2020).","journal-title":"Front. Immunol."},{"key":"51181_CR11","doi-asserted-by":"publisher","first-page":"950597","DOI":"10.3389\/fimmu.2022.950597","volume":"13","author":"T Xia","year":"2022","unstructured":"Xia, T. et al. Human dendritic cell targeting peptide can be targeted to porcine dendritic cells to improve antigen capture efficiency to stimulate stronger immune response. Front. Immunol. 13, 950597 (2022).","journal-title":"Front. Immunol."},{"key":"51181_CR12","doi-asserted-by":"publisher","first-page":"602802","DOI":"10.3389\/fimmu.2020.602802","volume":"11","author":"S Schmitt","year":"2020","unstructured":"Schmitt, S. et al. Fusion of bacterial flagellin to a dendritic cell-targeting \u03b1CD40 antibody construct coupled with viral or leukemia-specific antigens enhances dendritic cell maturation and activates peptide-responsive T cells. Front. Immunol. 11, 602802 (2020).","journal-title":"Front. Immunol."},{"issue":"11","key":"51181_CR13","doi-asserted-by":"publisher","first-page":"105324","DOI":"10.1016\/j.isci.2022.105324","volume":"25","author":"T Matsuda","year":"2022","unstructured":"Matsuda, T. et al. Efficient antigen delivery by dendritic cell-targeting peptide via nucleolin confers superior vaccine effects in mice. iScience 25 (11), 105324 (2022).","journal-title":"iScience"},{"key":"51181_CR14","unstructured":"Rupprecht, C. E., Fooks, A. R. & Abela-Ridder, B. Laboratory techniques in rabies 5th edn, Vol. 2 (World Health Organization, 2018)."},{"issue":"3","key":"51181_CR15","doi-asserted-by":"publisher","first-page":"e1008383","DOI":"10.1371\/journal.ppat.1008383","volume":"16","author":"L Belot","year":"2020","unstructured":"Belot, L. et al. Crystal structure of Mokola virus glycoprotein in its post-fusion conformation. PLoS Pathog. 16 (3), e1008383 (2020).","journal-title":"PLoS Pathog."},{"issue":"49","key":"51181_CR16","doi-asserted-by":"publisher","first-page":"7115","DOI":"10.1016\/j.vaccine.2006.06.078","volume":"24","author":"PS Wunderli","year":"2006","unstructured":"Wunderli, P. S. et al. The rabies peripheral challenge test: More accurate determination of vaccine potency. Vaccine. 24 (49), 7115\u20137123 (2006).","journal-title":"Vaccine"},{"key":"51181_CR17","doi-asserted-by":"crossref","unstructured":"Albertini, A. A. V., Ruigrok, R. W. H. & Blondel, D. Chap. 1-Rabies virus transcription and replication. In Advances in Virus Research (eds Jackson, A.C.), 1\u201322 (Academic Press, 2011).","DOI":"10.1016\/B978-0-12-387040-7.00001-9"},{"issue":"10","key":"51181_CR18","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.addr.2012.09.039","volume":"65","author":"X Chen","year":"2013","unstructured":"Chen, X., Zaro, J. L. & Shen, W. C. Fusion protein linkers: Property, design and functionality. Adv. Drug Deliv Rev. 65 (10), 1357\u20131369 (2013).","journal-title":"Adv. Drug Deliv Rev."},{"issue":"22","key":"51181_CR19","doi-asserted-by":"publisher","first-page":"11979","DOI":"10.3390\/ijms252211979","volume":"25","author":"NS Khudainazarova","year":"2024","unstructured":"Khudainazarova, N. S. et al. Prokaryote- and eukaryote-based expression systems: Advances in post-pandemic viral antigen production for vaccines. Int. J. Mol. Sci. 25 (22), 11979 (2024).","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"51181_CR20","doi-asserted-by":"publisher","first-page":"e0013010","DOI":"10.1371\/journal.pntd.0013010","volume":"19","author":"SS Lupitha","year":"2025","unstructured":"Lupitha, S. S. et al. Assessing anti-rabies vaccine response in humans: A rapid and high-throughput adaptable, pseudovirus-based neutralization assay as an alternative to rapid fluorescent focus inhibition test (RFFIT). PLoS Negl. Trop. Dis. 19 (4), e0013010 (2025).","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"2","key":"51181_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2149\/tmh.2014-35","volume":"43","author":"KA Nguyen","year":"2015","unstructured":"Nguyen, K. A. et al. Evaluation of rapid neutralizing antibody detection test against rabies virus in human sera. Trop. Med. Health. 43 (2), 111\u2013116 (2015).","journal-title":"Trop. Med. Health"},{"issue":"4","key":"51181_CR22","doi-asserted-by":"publisher","first-page":"e0011254","DOI":"10.1371\/journal.pntd.0011254","volume":"17","author":"Z Gong","year":"2023","unstructured":"Gong, Z. et al. A recombinant rabies virus chimera expressing the DC-targeting molecular MAB2560 shows enhanced vaccine immunogenicity through activation of dendritic cells. PLoS Negl. Trop. Dis. 17 (4), e0011254 (2023).","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"4","key":"51181_CR23","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1128\/JVI.01552-10","volume":"85","author":"Y Wen","year":"2011","unstructured":"Wen, Y. et al. Rabies virus expressing dendritic cell-activating molecules enhances the innate and adaptive immune response to vaccination. J. Virol. 85 (4), 1634\u20131644 (2011).","journal-title":"J. Virol."},{"issue":"1","key":"51181_CR24","doi-asserted-by":"publisher","first-page":"831","DOI":"10.18632\/oncotarget.23160","volume":"9","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y. et al. Recombinant rabies virus with the glycoprotein fused with a DC-binding peptide is an efficacious rabies vaccine. Oncotarget 9 (1), 831\u2013841 (2018).","journal-title":"Oncotarget"},{"issue":"5","key":"51181_CR25","doi-asserted-by":"publisher","first-page":"e63384","DOI":"10.1371\/journal.pone.0063384","volume":"8","author":"M Zhou","year":"2013","unstructured":"Zhou, M. et al. Recombinant rabies viruses expressing GM-CSF or flagellin are effective vaccines for both intramuscular and oral immunizations. PLoS One. 8 (5), e63384 (2013).","journal-title":"PLoS One"},{"issue":"1","key":"51181_CR26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12917-017-1038-z","volume":"13","author":"RMS Pimburage","year":"2017","unstructured":"Pimburage, R. M. S. et al. Sero-prevalence of virus neutralizing antibodies for rabies in different groups of dogs following vaccination. BMC Vet. Res. 13 (1), 133 (2017).","journal-title":"BMC Vet. Res."},{"issue":"4","key":"51181_CR27","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3390\/vaccines1040527","volume":"1","author":"J Terhune","year":"2013","unstructured":"Terhune, J., Berk, E. & Czerniecki, B. J. Dendritic cell-induced Th1 and Th17 cell differentiation for cancer therapy. Vaccines (Basel). 1 (4), 527\u2013549 (2013).","journal-title":"Vaccines (Basel)"},{"issue":"24","key":"51181_CR28","doi-asserted-by":"publisher","first-page":"eabp9151","DOI":"10.1126\/sciadv.abp9151","volume":"8","author":"HM Callaway","year":"2022","unstructured":"Callaway, H. M. et al. Structure of the rabies virus glycoprotein trimer bound to a prefusion-specific neutralizing antibody. Sci. Adv. 8 (24), eabp9151 (2022).","journal-title":"Sci. Adv."},{"issue":"32","key":"51181_CR29","doi-asserted-by":"publisher","first-page":"e2204078119","DOI":"10.1073\/pnas.2204078119","volume":"119","author":"CM Backlund","year":"2022","unstructured":"Backlund, C. M. et al. Cell-penetrating peptides enhance peptide vaccine accumulation and persistence in lymph nodes to drive immunogenicity. Proc. Natl. Acad. Sci. U S A. 119 (32), e2204078119 (2022).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"11","key":"51181_CR30","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1016\/j.biomaterials.2010.12.054","volume":"32","author":"A Bandyopadhyay","year":"2011","unstructured":"Bandyopadhyay, A. et al. The impact of nanoparticle ligand density on dendritic-cell targeted vaccines. Biomaterials 32 (11), 3094\u20133105 (2011).","journal-title":"Biomaterials"},{"issue":"10","key":"51181_CR31","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.7150\/ijms.87134","volume":"20","author":"Q Li","year":"2023","unstructured":"Li, Q. et al. Immunogenicity and antigenicity of the ectodomain of rabies virus glycoprotein stably expressed in HEK293T cells. Int. J. Med. Sci. 20 (10), 1282\u20131292 (2023).","journal-title":"Int. J. Med. Sci."},{"key":"51181_CR32","doi-asserted-by":"publisher","unstructured":"Zhao, H. et al. Immune response of inactivated rabies vaccine inoculated via intraperitoneal, intramuscular, subcutaneous and needle-free injection technology-based intradermal routes in mice. Int. J. Mol. Sci. 24 https:\/\/doi.org\/10.3390\/ijms241713587 (2023).","DOI":"10.3390\/ijms241713587"},{"key":"51181_CR33","doi-asserted-by":"publisher","first-page":"1099991","DOI":"10.3389\/fimmu.2022.1099991","volume":"13","author":"S Bai","year":"2022","unstructured":"Bai, S. et al. A single vaccination of nucleoside-modified Rabies mRNA vaccine induces prolonged highly protective immune responses in mice. Front. Immunol. 13, 1099991 (2022).","journal-title":"Front. Immunol."},{"issue":"2","key":"51181_CR34","doi-asserted-by":"publisher","first-page":"152","DOI":"10.37349\/ei.2024.00134","volume":"4","author":"MP Aguiar","year":"2024","unstructured":"Aguiar, M. P. & Vieira, J. H. Entrance to the multifaceted world of CD4\u2009+\u2009T cell subsets. Explor. Immunol. 4 (2), 152\u2013168 (2024).","journal-title":"Explor. Immunol."},{"issue":"5","key":"51181_CR35","doi-asserted-by":"publisher","first-page":"e0323823","DOI":"10.1371\/journal.pone.0323823","volume":"20","author":"HP Lang","year":"2025","unstructured":"Lang, H. P. et al. Rabies vaccination induces a CD4\u2009+\u2009TEM and CD4\u2009+\u2009CD8+ TEMRA TH1 phenotype in dogs. PLoS One. 20 (5), e0323823 (2025).","journal-title":"PLoS One"},{"issue":"6","key":"51181_CR36","doi-asserted-by":"publisher","first-page":"e0004746","DOI":"10.1371\/journal.pntd.0004746","volume":"10","author":"M Schnee","year":"2016","unstructured":"Schnee, M. et al. An mRNA vaccine encoding rabies virus glycoprotein induces protection against lethal infection in mice and correlates of protection in adult and newborn pigs. PLoS Negl. Trop. Dis. 10 (6), e0004746 (2016).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"51181_CR37","doi-asserted-by":"crossref","unstructured":"Kiflu, A. B. The immune escape strategy of rabies virus and its pathogenicity mechanisms. Viruses. 16(11). (2024).","DOI":"10.3390\/v16111774"},{"issue":"1","key":"51181_CR38","doi-asserted-by":"publisher","first-page":"2368080","DOI":"10.1080\/21505594.2024.2368080","volume":"15","author":"T Xia","year":"2024","unstructured":"Xia, T. et al. Screening optimal DC-targeting peptide to enhance the immune efficacy of recombinant Lactobacillus expressing RHDV VP60. Virulence 15 (1), 2368080 (2024).","journal-title":"Virulence"},{"issue":"4","key":"51181_CR39","doi-asserted-by":"publisher","first-page":"e0003709","DOI":"10.1371\/journal.pntd.0003709","volume":"9","author":"K Hampson","year":"2015","unstructured":"Hampson, K. et al. Estimating the global burden of endemic canine rabies. PLoS Negl. Trop. Dis. 9 (4), e0003709 (2015).","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"51181_CR40","doi-asserted-by":"publisher","first-page":"2389115","DOI":"10.1080\/22221751.2024.2389115","volume":"13","author":"J Liu","year":"2024","unstructured":"Liu, J. et al. A nucleoside-modified mRNA vaccine forming rabies virus-like particle elicits strong cellular and humoral immune responses against rabies virus infection in mice. Emerg. Microbes Infect. 13 (1), 2389115 (2024).","journal-title":"Emerg. Microbes Infect."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51181-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51181-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51181-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T06:15:08Z","timestamp":1783059308000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51181-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,3]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["51181"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-51181-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,3]]},"assertion":[{"value":"2 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were performed in accordance with the guidelines for the care and use of laboratory animals and were approved by the ethics committees of Islamic Azad University- Science and Research Branch, with approval ID: IR.IAU.SRB.REC.1403.370.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20427"}}